Table 3.
Biomarkers | Control male | Control Female | Treated male mice | Treated female mice |
---|---|---|---|---|
HB (g/L) | 12.20 ± 1.00a | 11.10 ± 1.20 a | 15.90 ± 1.29 b | 14. 80 ± 1.98b |
RBCs(million cells/uL) | 6.30 ± 0.91a | 6.00 ± 0.90 a | 6.80 ± 0.98 a | 6.89 ± 0.98 a |
PCV (%) | 41.80 ± 4.10a | 40.90 ± 3.50 a | 41.00 ± 2.97a | 41.65 ± 4.00a |
WBCs(× 109/L) | 9.97 ± 112.50a | 10.00 ± 120.50 a | 10.500 ± 110.50 a | 10.067 ± 100.00 a |
Neutrophils (×109/L) | 20.69 ± 1.00a | 19.65 ± 1.20 a | 18.00 ± 1.00a | 19.00 ± 1.00a |
Eosinophil (x100 cells /ul). |
1.69 ± 0.07a | 1.59 ± 0.05a | 1.65 ± 0.02a | 1.66 ± 0.04a |
Lymphocyte(109/L) | 79.00 ± 8.20a | 78.00 ± 3.50 a | 77.00 ± 7.10a | 75.62 ± 7.10a |
Monocyte(109/L) | 1.66 ± 0.05a | 1.63 ± 0.14 a | 1.60 ± 0.12 a | 1.59 ± 0.15a |
Platelets (x 109/L) | 740.00 ± 50.00a | 770.00 ± 65.00 a | 800.00 ± 60.00 a | 780.00 ± 45.00 a |
Data are Means ± SD of 15 mice in treated group. Statistical analysis is carried out using Co-state and SPSS computer programs (version 7), where unshared letter is significant at P ≤ 0.05.